Table III.
Asymptomatic episodes (n = 2) | Symptomatic episodes (n = 28) | |
---|---|---|
HRV + CP | 1 | 3 |
HRV + HCoV OC43 | 1 | 3 |
HRV + MP | 4 | |
HRV + HCoV 229E | 5 | |
HRV +IVB | 1 | |
HRV + RSVB | 1 | |
HRV + CP + MP | 1 | |
HRV + CP + RSVB | 1 | |
HRV + MP + HCoV OC43 | 1 | |
HCoV 229E + HCoV OC43 | 1 | |
HCoV 229E + HCoV NL63 | 1 | |
HCoV 229E + CP | 1 | |
HCoV 229E + hMPV + EV | 1 | |
HCoV 229E + HCoV OC43 + hMPV | 1 | |
HCoV 229E + HCoV OC43 + EV | 1 | |
HCoV OC43 + RSVA | 1 | |
HCoV OC43 + RSVB | 1 |
HRV, human rhinovirus; CP, Chlamydophila pneumoniae; HcoV, human coronavirus; MP, Mycoplasma pneumoniae; IVB, influenza virus B; hMPV, human metapneumovirus; EV, enterovirus.